HGF and neoplasm: In mice bearing HGF-independent subcutaneous EBC-1 tumors with METamp, tepotinib (free base) 15 mg/kg QD led to tumor growth inhibition, with complete regressions in 7/10 animals, whereas 25 mg/kg QD led to complete regression in 10/10 mice (30, 33).